Clinical Trials Directory

Randomized Controlled Trial for Assessment of a Novel Non-Pharmacologic Intervention for Decrease in Altitude Illness

The study is examining if an over-the-counter device (Theravent) worn while sleeping can reduce acute mountain sickness upon awakening in a high altitude trekking population.

Stanford is not currently accepting new patients for this trial. You may want to check to see if other locations are recruiting.



  • device : Control
  • device : Theravent

Phase: N/A


Ages Eligible For Study:

18 Years - 65 Years

Inclusion Criteria

- ages 18-65 - Lake Louise Score (LLS) of < 3 - Have not taken NSAIDs, acetazolamide, or corticosteroids in the prior week - Have not traveled above 4200 m in the prior week. - First night in Pheriche or Dingboche

External Links

Contact information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Grant S Lipman, MD
Not Recruiting

Footer Links: